If you liked this article you might like

What to Expect From European Pharmaceuticals' First Quarter Results
Europe Benchmarks Pare Losses but Caution Remains
Mylan Has Been Pounded, but the Pain May be Far from Over
Astrazeneca Scores Milestone Victory in Oncology